A Prospective Cohort Study on the Usage, Safety, and Efficacy of Delamanid in Patients With Pulmonary Multidrug-Resistant Tuberculosis in South Korea. [PDF]
Mok J +7 more
europepmc +1 more source
Latent Profile Analysis and Influencing Factors of Medication-Related Burden in Multidrug-Resistant Tuberculosis Patients in Chengdu, China. [PDF]
Li Y +13 more
europepmc +1 more source
Therapeutic Opportunities in Infectious Diseases: Highlights from the Society of Medicines Research Symposium, held on March 14th 2013 at the National Heart & Lung Institute, London, UK [PDF]
Alderton, W K +3 more
core +1 more source
Prediction of risk factors associated with the development of multidrug-resistant tuberculosis in patients with tuberculosis. [PDF]
Chen H +8 more
europepmc +1 more source
From Repurposing to Refinement: Optimizing Levofloxacin for Treatment of Multidrug-Resistant Tuberculosis. [PDF]
Yim JJ.
europepmc +1 more source
Real-world safety profile of novel anti-multidrug-resistant tuberculosis drugs: a disproportionality analysis based on the FAERS database. [PDF]
Zhao L, Zeng L, Qian Y, Zhao W, Xie R.
europepmc +1 more source
Prevalence of Multidrug-Resistant Tuberculosis and Its Association With Previous Treatment History in Adults. [PDF]
Ahmad Mughal M +7 more
europepmc +1 more source
Evaluating the cost-effectiveness of levofloxacin therapy for household contacts of multidrug-resistant tuberculosis in Vietnam. [PDF]
Hasan T +9 more
europepmc +1 more source

